Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Clinical Classification of Age-related Macular Degeneration
20131.3k citationsAlan C. Bird, Usha Chakravarthy et al.Ophthalmologyprofile →
Adenovector-mediated gene transfer of active transforming growth factor-beta1 induces prolonged severe fibrosis in rat lung.
1997836 citationsKarl G. Csaky et al.Journal of Clinical Investigationprofile →
C5 Inhibitor Avacincaptad Pegol for Geographic Atrophy Due to Age-Related Macular Degeneration
2020307 citationsKeith Westby, Karl G. Csaky et al.Ophthalmologyprofile →
Drug Approval for the Treatment of Geographic Atrophy: How We Got Here and Where We Need to Go
202438 citationsKarl G. Csaky, Jason Miller et al.profile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
This map shows the geographic impact of Karl G. Csaky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karl G. Csaky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karl G. Csaky more than expected).
This network shows the impact of papers produced by Karl G. Csaky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karl G. Csaky. The network helps show where Karl G. Csaky may publish in the future.
Co-authorship network of co-authors of Karl G. Csaky
This figure shows the co-authorship network connecting the top 25 collaborators of Karl G. Csaky.
A scholar is included among the top collaborators of Karl G. Csaky based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Karl G. Csaky. Karl G. Csaky is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Anegondi, Neha, Srinivas R. Sadda, Steffen Schmitz-Valckenberg, et al.. (2024). Visual Loss in Geographic Atrophy. Ophthalmology. 132(4). 420–430.3 indexed citations
Csaky, Karl G., Keith Westby, & Kourous A. Rezaei. (2020). Avacincaptad Pegol, A Novel C5 Inhibitor, Significantly Reduces the Mean Rate of Geographic Atrophy Growth in a Pivotal Clinical Trial. Investigative Ophthalmology & Visual Science. 61(7). 1943–1943.1 indexed citations
12.
Wang, Yi‐Zhong, et al.. (2015). Diabetic Retinopathy And the MyVisionTrack® App (DRAMA) Study. Investigative Ophthalmology & Visual Science. 56(7). 516–516.4 indexed citations
13.
Lutz, Rainer, et al.. (2007). Analysis of Drug Elimination Kinetics After Subconjunctival Injection Using Magnetic Resonance Imaging. Investigative Ophthalmology & Visual Science. 48(13). 5785–5785.1 indexed citations
14.
Csaky, Karl G., et al.. (2006). Over Expression Apoptosis Inducing Factor (AIF) Sensitizes Human Retinal Pigment Epithelium (HRPE) to Oxidant Induced Cell Death. Investigative Ophthalmology & Visual Science. 47(13). 1380–1380.1 indexed citations
15.
Csaky, Karl G., Hanna R. Coleman, Emily Y. Chew, et al.. (2005). Anterior Subtenon's Triamcinolone Acetonide (ASTTA) Injection for the Treatment of Diabetic Macular Edema: Animal and Clinical Findings. Investigative Ophthalmology & Visual Science. 46(13). 4670–4670.2 indexed citations
16.
Strunnikova, N., et al.. (2004). Differences in Gene Expression Profiles in Dermal Fibroblasts elicited by Nonlethal Injury from Control and Patients with Age Related Macular Degeneration (AMD). Phase I case–control study. Investigative Ophthalmology & Visual Science. 45(13). 1826–1826.1 indexed citations
17.
Caicedo, Alejandro, et al.. (2004). Aged bone marrow transfers age–related pathology into young recipients in experimental choroidal neovascularization (CNV).. Investigative Ophthalmology & Visual Science. 45(13). 1853–1853.2 indexed citations
18.
Csaky, Karl G.. (2004). Phase II Trial of Celebrex in Photodynamic Therapy (C–PDT) for Neovascular Age–related Macular Degeneration (AMD): Rationale and Baseline Characteristics. Investigative Ophthalmology & Visual Science. 45(13). 1186–1186.2 indexed citations
19.
Caicedo, Alejandro, et al.. (2003). The Effects of Nicotine in Choroidal Neovascularization: Characterization of Nicotinic Receptors in Choroid and Reduction of Choroidal Neovascularization Size and Severity via Receptor Blockade. Investigative Ophthalmology & Visual Science. 44(13). 3933–3933.3 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.